论文部分内容阅读
北京医院杨杰孚教授谈“急性心肌梗死室性心律失常的药物治疗”杨杰孚教授首先指出,室性心律失常常发生在急性心肌梗死(AMI)后,在AMI急性期,缺血及再灌注均可引起室性心律失常,但两者预后有较大差异,因此治疗前要对缺血及再灌注引起室性心律失常进行区别。再灌注心律失常的临床特点是胸痛等症状缓解或消失,其心电图(ECG)特点主要是ST-T改变,一般预后良好,多数不需要使用抗心律失常药物。缺血性心律失常的临床特点是胸痛等症状不缓解或加重,ECG常表现ST-T改变,多数预后不良,需要立即处理。
Professor Yang Jiefu Beijing Hospital talk about “drug treatment of ventricular arrhythmias in acute myocardial infarction,” Professor Yang Jie Fu first pointed out that ventricular arrhythmias often occur after acute myocardial infarction (AMI), AMI acute phase, ischemia and reperfusion Can cause ventricular arrhythmia, but the prognosis of the two have a greater difference, so before treatment to ischemia and reperfusion induced ventricular arrhythmias were distinguished. The clinical feature of reperfusion arrhythmia is the relief or disappearance of symptoms such as chest pain. The ECG characteristics are mainly ST-T changes. The general prognosis is good, and most do not need to use anti-arrhythmic drugs. The clinical feature of ischemic arrhythmia is that chest pain and other symptoms do not alleviate or aggravate, ECG often shows ST-T changes, most of the prognosis is poor, need immediate treatment.